Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | 0.00% |
|
-16.79% | -61.36% |
05-09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.36% | 42.79M | |
+15.19% | 121B | |
+19.91% | 114B | |
-19.80% | 20.43B | |
-15.92% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B | |
+119.39% | 10.96B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Top Stories at Midday: US Q1 GDP Revised Higher; Jobless Claims Post Surprise Drop; Powell Reiterates Comments; BioXcel Therapeutics Tumbles